Aktuelle Nachrichten

vom 12.01.2026 17:31 Uhr
13:21GardaWorld Announces Financial Guidance for the Fiscal Year Ending January 31, 2026
13:21GardaWorld Announces Financial Guidance for the Fiscal Year Ending January 31, 2026
13:20Krieg als Werbung: Moskau meldet Auftragsrekord für Waffen
13:20SPD sucht neues Wirtschaftsmodell für Deutschland
13:19ROUNDUP 2/Drohende Anklage: Fed-Chef Powell spricht von Einschüchterungsversuch
13:17Zollstreit: EU macht E-Auto-Exporteuren in China Angebot - Mindestpreise
13:17Commodities im Fokus: So bewegen sich Öl & Co. am Mittag
13:16EQT Life Sciences backs Kinaset Therapeutics' USD103 million Series B to advance inhaled therapeutic for treatment of respiratory diseases
13:11Qualcomm: CES-Impulse und KI-Fantasie
13:11Qualcomm: CES-Impulse und KI-Fantasie
13:10Kipling Group Appoints Michael Case as President and Chief Operating Officer
13:09Iran wirft USA und Israel Einflussnahme auf Proteste vor
13:06Ethereum 2026 Outlook: staked, slightly inflationary, levered by scalability
13:05Pickleball Canada Selects Pickleplex Social Club as Host Venue of 2026 Pickleball Canada National Championship
13:05Pickleball Canada Selects Pickleplex Social Club as Host Venue of 2026 Pickleball Canada National Championship
13:04ANALYSE-FLASH: MWB Research hebt FMC auf 'Buy' und Ziel auf 47 Euro
13:04ANALYSE-FLASH: JPMorgan belässt Rheinmetall auf 'Overweight' - Ziel 2250 Euro
13:04ECARX Holdings Inc. Announces US$45.6 million Strategic Investment from Geely Holding Group
13:03KORREKTUR/Umfrage: Viele finden 13,90 Euro Mindestlohn zu wenig
13:03SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer's Disease
13:02ESSL leading study to find where and why damaging hail is getting worse
13:02ESSL leading study to find where and why damaging hail is getting worse
13:01AKTIE IM FOKUS: Rüstungsfantasie treibt Deutz auf Hoch seit 2007
13:01Helios HVACR deploys A.I. nationwide in partnership with Bluon
13:00A2Z Cust2Mate Expands into Toy Retail with Large-Scale Smart Cart Deployments
13:00Golden Arrow Confirms Near-Surface Gold Zone with Trench Results including 76.7m @ 1.01 g/t Au at Noemi Gold Target, San Pietro Project, Chile
13:00Accredant Capital Advises Segue Sustainable Infrastructure on Sale of Community Solar Portfolio to Radial Power
13:00NEXT with Michael Sonnenfeldt Returns for Season 2, Featuring Visionary Entrepreneurs Shaping What Comes Next
13:00Avista-Backed WellSpring Consumer Healthcare Acquires Established OTC Skincare Brands, DerMend® and Recticare®
13:00GTCR Completes Sale of Worldpay to Global Payments
13:00CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
13:00Waystar Introduces Agentic AI to Advance Toward the Autonomous Revenue Cycle
13:00EDETEK to Present at the 44th Annual J.P. Morgan Healthcare Conference
13:00ARTBIO Announces Dosing of Two Cohorts with AB001 in ARTISAN, a Phase 1 Alpha Radioligand Therapy Clinical Trial for Metastatic Castration Resistant Prostate Cancer
13:00New 2026 ezPaycheck Supports the One Big Beautiful Bill!
13:00Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation
13:00Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026
13:00SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan
13:00Corero Network Security Delivers Strong Full-Year 2025 Performance Driven by Global Customer Wins and Expanding Enterprise Adoption
13:00NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes Without Immune Suppression
13:00Doseology Engages McKinney Regulatory Science Advisors to Advance Innovative Oral Pouch Product Development through Science and Regulatory Expertise
13:00Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity
13:00AZIO receives $100 Million worth of Government Purchase Orders, Advances $200 Million Regional Pipeline and Scalable U.S. AI Infrastructure Expansion
13:00LiquiDonate Releases 2026 Returns Fraud Report
13:00Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepressants
13:00WindRose Health Investors Makes Investment in Avalon Healthcare Solutions
13:00Haisco Grants Global Rights of Innovative Drug HSK39004 to AirNexis in Deal Exceeding USD 1 Billion
13:00Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib (LNK01001) in Rheumatoid Arthritis
13:00SOPHiA GENETICS gibt vorläufige Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2025 bekannt, veröffentlicht Prognose für 2026 und kündigt Plan für Wechsel in der Geschäftsführung an
13:00Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepressants